This part 1 does not create a private cause of action against a manufacturer of an investigational drug, biological product, or device, or against any other person or entity involved in the care of an eligible patient using the investigational drug, biological product, or device, for any harm done to the eligible patient resulting from the investigational drug, biological product, or device, so long as the manufacturer or other person or entity is complying in good faith with the terms of this part 1, unless there was a failure to exercise reasonable care.

Source: L. 2014: Entire article added, (HB 14-1281), ch. 220, p. 827, § 1, effective May 17. L. 2025: Entire section amended, (HB 25-1270), ch. 211, p. 954, § 4, effective May 19.